CRC Group has completed its acquisition of Atrium, a managing agency at Lloyd's, marking a key step in the firm's global ...

CRC Group has agreed to acquire Euclid Transactional, a provider of transactional insurance solutions that focuses on ...

CRC Group has signed a definitive agreement to acquire Euclid Transactional, a global managing general agent specializing in ...

CYPRUS: The Cypriot Presidency of the Council of the European Union in the first half of 2026 has drawn new attention to long ...

Brenus Pharma, a clinical stage biotechnology company unlocking the immune system in vivo to fight solid tumors, announced the successful completion of the first dose levels in its ongoing ...

The cumulative incidence of CRLM has declined, with survival gains mainly in synchronous cases, highlighting the need for ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield blood test for ...

New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment.

Noetik, an AI-native biotech company developing self-supervised machine learning and high-throughput spatial data to develop ...

Flerie AB's (publ) portfolio company KAHR Bio announced a median overall survival of 17.5 months in its Phase II trial with DSP107, combined with the anti-PD-L1 immunotherapy atezolizumab, in patients ...

From curated arrival lobbies and concierge-style services to spa-grade wellness zones and designer lounges, homebuyers are moving beyond square footage to experience-led living ...

A recent study reveals that bacteria residing within colorectal tumors form distinct ecosystems closely linked to disease ...